4basebio PLC Share Price
Stocks
4BB
GB00BMCLYF79
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 525.00 GBX | 0.00% |
|
0.00% | -14.63% |
| 06-25 | 4basebio PLC Appoints Cornel Chiriac as Director, Effective May 31, 2026 | CI |
| 06-15 | 4basebio appoints Jeff Coller to Strategic Advisory Board | AN |
| Market Cap | 81.58M 110M 96.01M 88.88M 154M 10.59B 157M 1.06B 415M 5.18B 412M 404M 17.85B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 81.88M 110M 96.36M 89.2M 155M 10.63B 158M 1.06B 417M 5.2B 414M 405M 17.91B | EV / Sales 2026 * |
29.2x | EV / Sales 2027 * | 8.94x |
| Free-Float |
38.72% | Yield 2026 * |
-
| Yield 2027 * | - |
| Current month | +0.96% | ||
| 3 months | +3.96% | ||
| 6 months | -11.02% | ||
| Current year | -14.63% |
| 1 week | 500 |  | 550 |
| 1 month | 500 | | 550 |
| Current year | 420 | | 630 |
| 1 year | 420 | | 1,020 |
| 3 years | 420 | | 1,820 |
| 5 years | 390 | | 1,820 |
| 10 years | 175 | | 1,820 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amy Walker
CEO | Chief Executive Officer | 33 | 09/02/2026 |
Scott Lorimer
COO | Chief Operating Officer | - | 11/03/2026 |
Daniel Jones
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 52 | 12/11/2024 | |
| Director/Board Member | 55 | 12/11/2024 | |
Heikki Lanckriet
BRD | Director/Board Member | 48 | 21/12/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21/05/26 | Buy | Chief Executive Officer | 1,863 | 0.0120% | ||
| 16/02/26 | Buy | Chief Executive Officer | 2,650 | 0.0171% | ||
| 11/02/26 | Buy | Director | 3,000 | 0.0193% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -47.50% | -7.08% | 110M | |
| -1.07% | +0.38% | +2.06% | +5.66% | 50.35B | |
| -2.85% | -5.58% | +373.90% | +572.09% | 39.21B | |
| +1.78% | +3.29% | +33.49% | -4.80% | 34.52B | |
| +1.98% | +5.15% | +17.69% | +61.68% | 34.6B | |
| +0.06% | -0.57% | +3.35% | +27.42% | 27.05B | |
| -3.27% | -6.27% | - | - | 16.68B | |
| +1.64% | +1.11% | +72.02% | +121.18% | 15.11B | |
| +0.29% | +3.64% | +15.30% | +17.80% | 13.85B | |
| -1.21% | +2.74% | +16.77% | -30.96% | 13.18B | |
| Average | +0.01% | +0.73% | +54.12% | +84.77% | 24.47B | |
| Weighted average by Cap. | +0.13% | +0.70% | +79.57% | +118.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.8M 3.77M 3.3M 3.05M 5.3M 363M 5.39M 36.37M 14.25M 178M 14.15M 13.86M 613M | 12M 16.17M 14.12M 13.07M 22.7M 1.56B 23.11M 156M 61.09M 762M 60.66M 59.38M 2.63B |
| Net income | -17.1M -23.04M -20.12M -18.63M -32.35M -2.22B -32.93M -222M -87.05M -1.09B -86.44M -84.62M -3.74B | - |
| Net Debt | 300K 404K 353K 327K 568K 38.95M 578K 3.9M 1.53M 19.04M 1.52M 1.48M 65.63M | 25.7M 34.63M 30.25M 28M 48.62M 3.34B 49.48M 334M 131M 1.63B 130M 127M 5.62B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | GBX 525.00 | 0.00% | 94 |
| 15/07/26 | GBX 525.00 | 0.00% | 8 |
| 14/07/26 | GBX 525.00 | 0.00% | 473 |
| 13/07/26 | GBX 525.00 | 0.00% | 57 |
| 10/07/26 | GBX 525.00 | 0.00% | 81 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 4BB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition